Browsing Tag
Novasight Hybrid
2 posts
Conavi’s FDA-cleared Novasight heads for U.S. hospitals after emergency-like financing
Conavi Medical ended June with only C$0.9 million of cash before raising C$10 million to fund the U.S. launch of its FDA-cleared next-generation Novasight Hybrid IVUS-OCT coronary imaging system.
Conavi Medical (TSXV: CNVI) launches public offering to fund Novasight Hybrid U.S. rollout
Conavi Medical is raising capital via share and warrant offering to fund the U.S. launch of its next-gen Novasight Hybrid imaging system. Find out what’s next.